Psychopharmacological therapy and suicide of inpatients with depressive psychoses

Archives of Suicide Research

Volumn 4, Issue 2, 1998, Pages 143-155

  Krupinski, Martin ^a   Fischer, Alfred ^a   Grohmann, Renate ^a   Engel, Rolf R ^a   Hollweg, Matthias ^a   Möller, Hans Jürgen ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Affective psychoses; Depression; Major affective disorder; Psychopharmacology; Suicidal behavior; Suicide

Indexed keywords

ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIPERIDEN; HYPNOTIC AGENT; LITHIUM; NEUROLEPTIC AGENT; PLACEBO; TRANQUILIZER;

ARTICLE; BIPOLAR DEPRESSION; COMPARATIVE STUDY; CONTROLLED STUDY; HOSPITAL PATIENT; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MANIC DEPRESSIVE PSYCHOSIS; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SUICIDE;

EID: 0031744429     PISSN: 13811118     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009615914868     Document Type: Article

References (37)

1. Ahrens, B., Grof, P., Moller, H. J., Muller-Oerlinghausen, B. & Wolf, T. (1995). Extended survival of patients on long-term lithium treatment. Canadian Journal of Psychiatry, 40(5), 241-6.
2. Cohen, S., Leonard, C. V., Farberow, N. L. & Shneidman, E. S. (1964). Tranquilizers and suicide in the schizophrenic patient. Archives of General Psychiatry, 11, 312-321.
3. Coppen, A. (1994). Depression as a lethal disease: Prevention strategies. Journal of Clinical Psychiatry, 55(4,suppl), 37-45.
4. Finzen, A. (1988). Der Patientensuizid: Untersuchungen , Analysen, Berichte zur Selbsttötung psychisch Kranker während der Behandlung. Bonn: Psychiatrie-Verlag.
5. Galdi, J. & Hirsch, S. R. (1983). The causality of depression in schizophrenia. British Journal of Psychiatry, 142, 621-625.
6. Glen, A., Dodd, M., Hulme, N. & Kreitman, N. (1979). Mortality on lithium. Neuropsychobiology, 5, 167-169.
7. Goldney, R. D., Positano, S., Spence, N. & Rosenman, S. (1985). Suicide in association with psychiatric hospitalisation. Australian and New Zealand Journal of Psychiatry, 19, 177-183.
8. Grohmann, R., Rüther, E. & Schmidt, L. G. (Eds.). (1994). Unerwünschte Wirkungen von Psychopharmaka. Ergebnissse der AMÜP-Studie. Berlin Heidelberg: Springer.
9. Guy, W. & Ban, T. A. (Eds.). (1982). The AMDP-System. Manual for the assessment and documentation of psychopathology. Berlin Heidelberg, New York: Springer.
10. Guze, S. & Robins, E. (1970). Suicide and primary affective disorder. British Journal of Psychiatry, 117, 437-438.
11. Helmchen, H. (1985). The AMDP. In P. Pichot (Ed.), Psychiatry. The state of the art. Vol. 1. Clinical Psychopathology, nomenclature and classification (pp. 141-146). New York: Plenum Press.
12. Hessö, R. (1977). Suicide in Norwegian, Finnish, and Swedish psychiatric hospitals. Archiv für Psychiatrie und Nervenkrankheiten, 224(2), 119-27.
13. Hussar, A. E. (1962). Effect of tranquilizers on medical morbidity and mortality in a mental hospital. Journal of the American Medical Association, 179, 682-686.
14. Kapur, S., Mieczkowski, T. & Mann, J. J. (1992). Antidepressant medications and the relative risk of suicide attempt and suicide. Journal of the American Medical Association, 268(24), 3441-5.
15. Lepkifker, E., Horesh, N. & Floru, S. (1985). Long-term lithium prophylaxis in recurrent unipolar depression. Acta psychiatrica Belgica, 85, 434-443.
16. Litovitz, T., Bailey, K., Schmitz, B., Holm, K. & Klien-Schwarz, W. (1991). 1990 annual Report of the American Association of Poison Control Centers National Data Collection System. American Journal of Emergency Medicine, 9, 461-509.
17. Menninger, K. (1938). Man against Himself. London: Harrap.
18. Modestin, J. (1985). Antidepressive therapy in depressed clinical suicides. Acta psychiatrica Scandinavica, 71, 111-116.
19. Modestin, J. & Schwarzenbach, J. (1992). Effect of psychopharmacotherapy on suicide risk in discharged psychiatric inpatients. Acta psychiatrica Scandinavica, 85, 173-175.
20. Möller, H.-J. (1992). Antidepressants - Do they decrease or increase suicidality. Pharmacopsychiatry, 25, 249-253.
21. Möller, H.-J. (1995). Suizidalität unter Antidepressivabehandlung. In M. Wolfersdorf & W. P. Kaschka (Eds.), Suizidalität - Die biologische Dimension . Berlin Heidelberg: Springer.
22. Möller, H.-J. & Zerssen, D. v. (1981). Depressive Symptomatik im stationären Behandlungsverlauf von 280 schizophrenen Patienten. Pharmakopsychiatrie, 14, 172-179.
23. Muller-Oerlinghausen, B., Ahrens, B., Grof, E., Grof, P., Lenz, G., Schou, M., Simhandl, C., Thau, K., Volk, J., Wolf, R. & et al. (1992a). The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness. Acta psychiatrica Scandinavica, 86(3), 218-22.
24. Muller-Oerlinghausen, B., Muser-Causemann, B. & Volk, J. (1992b). Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. Journal of Affective Disorders, 25(4), 261-9.
25. Myers, D. & Neal, C. (1978). Suicide in psychiatric patients. British Journal of Psychiatry, 133, 38-44.
26. Nilsson, A. (1995). Mortality in recurrent mood disorders during periods on and off lithium. A complete population study in 362 patients. Pharmacopsychiatry, 28(1), 8-13.
27. Norton, B. & Whalley, L. (1984). Mortality of a lithium treated population. British Journal of Psychiatry, 145, 277-282.
28. Pokomy, A. (1983). Prediction of suicide in psychiatric patients. Archives of General Psychiatry, 40, 249-257.
29. Price, L. H., Charney, D. S., Delgado, P. M. & Heninger, G. R. (1990). Lithium and serotonin function: implications for the serotonin hypothesis of depression. Psychopharmacology, 100, 3-12.
30. Rouillon, F., Philipps, R. & Serrurier, D. (1989). Recurrence of unipolar depression efficacy of maprotiline. Encéphale, 15, 527-534.
31. Roy, A. (1982). Risk factors for suicide in psychiatric patients. Archives of General Psychiatry, 39(9), 1089-95.
32. Roy, A. (1985). Suicide. A multidetermined act. Psychiatric Clinic of North America, 8(2), 243-50.
33. Taiminen, J. & Kujari, H. (1994). Antipsychotic medication and suicide risk among schizophrenic and paranoid inpatients. Acta psychiatrica Scandinavica, 90, 247-251.
34. Thies-Flechtner, K., Müller-Oerlinghausen, B., Seibert, W., Walther, A. & Greil, W. (1996). Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Pharmacopsychiatry, 29, 103-107.
35. Vestergaard, P. & Aagaard, J. (1991). Five-year mortality in lithium-treated manic-depressive patients. Journal of Affective Disorders, 21, 33-38.
36. Wickham, E. A. & Reed, J. V. (1987). Lithium for the control of aggressive and self-mutilating behaviour. International Clinical Psychopharmacology, 2, 181-190.
37. Wolfersdorf, M. (1989). Suizid bei stationären psychiatrischen Patienten. Regensburg: Roderer.